- Start
- Jul 16, 202690% CONFIDENCEfrom the source
Abbott Reports Q2 2026 Results and Raises Full-Year EPS Guidance
- Second-quarter sales were $12.593 billion, up 13.0% reported and 4.8% on a comparable basis that counts Exact Sciences in both years; GAAP diluted EPS was $0.53 on net earnings of $928 million, and adjusted diluted EPS was $1.31 against $1.26 a year earlier[1]
- Abbott raised its full-year 2026 adjusted diluted EPS guidance to $5.45 to $5.60 from $5.38 to $5.58, reaffirmed 6.5% to 7.5% comparable sales growth, and guided to $1.38 to $1.46 of adjusted EPS for the third quarter[1]
- Adjusted EPS beat the $1.28 analysts expected and diagnostics sales of $3.09 billion beat the $3.02 billion estimate; the shares rose 12%[3]
- Medical Devices sales were $5.853 billion (up 8.4% comparable, led by 13.4% in Electrophysiology), Diagnostics $3.092 billion (up 42.3% reported, with Cancer Diagnostics up 13.3% comparable on mid-teens Cologuard growth), Established Pharmaceuticals $1.499 billion (up 8.4%) and Nutrition $2.144 billion (down 3.1%)[1]
- Continuous glucose monitor sales grew 11.0% reported and 9.5% comparable, and Abbott returned $2.1 billion to shareholders in dividends and buybacks[1]
- Chief executive Robert Ford said to watch for U.S. launches of Libre Duo, the Amulet 360 left atrial appendage device, the coronary intravascular lithotripsy system and the TactiFlex Duo catheter over the next 12 months[5]
References 686% CONFIDENCE
The first entry is always the pin's source. Overall confidence is a weighted average of how firmly each reference supports the start and end times used above; a reference counts half as much for every 180 days older than the newest.
- [1]90%abbott.mediaroom.com/2026-07-16-Abbott-Reports-Second-Quarter-2026-Results-and-Raises-Full-Year-EPS-Guidanceabbott.mediaroom.com· Posted Sep 23, 2026· Starts Jul 16, 2026 ✓· 21% of score
The release, datelined "ABBOTT[5] PARK, Ill., July 16, 2026", says "Abbott will live-webcast its second-quarter earnings conference call ... at 8 a.m. Central time today", so the pin is 8 a.m. CDT (13:00 UTC) on 16 July 2026.
- [2]92%Abbott Laboratories Form 8-K: Results of Operations for the second quarter 2026sec.gov· Published Jul 16, 2026· 16% of score
Abbott's[5] Item 2.02 8-K: on 16 July 2026 Abbott announced its second-quarter 2026 results, furnishing the news release as Exhibit 99.1.
- [3]85%Abbott raises 2026 profit forecast on strength in diagnostics, medical devices (Reuters)aol.com· Published Jul 16, 2026· 16% of score
Reuters: adjusted EPS of $1.31 beat the $1.28 estimate, diagnostics sales of $3.09 billion beat $3.02 billion, and the shares rose 12%.[1]
- [4]78%Abbott Q2 2026 earnings beat, raises full-year profit guidance (Quartz)finance.yahoo.com· Published Jul 16, 2026· 16% of score
Quartz: $1.31 adjusted EPS against $1.26 a year earlier and a $1.28 estimate, $12.59 billion of sales, and third-quarter adjusted EPS guidance of $1.38 to $1.46.[1]
- [5]80%Abbott's Q2 2026 earnings call: What drove results and what should investors watch next?abbott.com· Published Jul 16, 2026· 16% of score
Abbott's own call write-up: Ford's takeaways and the U.S. launches to watch over the next 12 months (Libre Duo, Amulet 360, coronary IVL, TactiFlex Duo).
Suggest a correction
Something missing or wrong? Say it in your own words: a link that backs this pin up, a different start or end date and why, or a fact it lacks or gets wrong. The AI checks it against this pin's sources, searches for better ones, and adds any page that backs you up. The pin's own sources still count most.
